Link Between Rheumatoid Arthritis & Lung Disease
Trial Objectives
The purpose of this study is to determine the development and progression of rheumatoid arthritis -associated lung disease (RA-LD) over time and to learn about the body’s generation of auto-antibodies in the blood. Researchers are trying to understand who develops rheumatoid arthritis (RA) and which RA patients go on to develop RA-LD, as well as how to prevent and treat the disease
Who Can Participate
Individuals with rheumatoid arthritis (RA), interstitial lung disease (ILD) or lung fibrosis may be eligible to participate.
Age: 18+ Gender: Any
Estimated Time Commitment
6 in-person visits, performed every year over 4 years
Payment & Reimbursement
Payment: Not Provided
Travel Reimbursement: Not Available
Trial Location
National Jewish Main Campus, Denver, CO
Trial Sponsors
Pfizer
Principal Investigators
Joshua J. Solomon, MD
Co-Investigators
Michael P. Mohning, MD